P2‐027: TARGET ENGAGEMENT IN A PHASE II CLINICAL TRIAL OF AAV2‐NGF GENE THERAPY FOR ALZHEIMER'S DISEASE. (1st July 2006) - Castle, Michael J.; Baltanas, Fernando Calvo; Kovacs, Imre; Nagahara, Alan H.; Bankiewicz, Krystof S.; Barba, David; Tuszynski, Mark H.